El CDT, que incluye al Carcinoma Papilar y al Carcinoma Folicular de tiroides, supone más del 90% de los tumores tiroideos, que son la neoplasisa del origen endocrinológico más frecuente. A pesar de que su incidencia no es excesivamente elevada, su prevalencia sí que lo es, debido a su bajo índice de mortalidad. Teniendo en cuenta la elevada...
-
December 16, 2016 (v1)PublicationUploaded on: December 2, 2022
-
September 20, 2022 (v1)Publication
Nowadays, neither imaging nor pathology evaluation can accurately predict the aggressiveness or treatment resistance of pituitary tumors at diagnosis. However, histological examination can provide useful information that might alert clinicians about the nature of pituitary tumors. Here, we describe our experience with a silent corticothoph...
Uploaded on: March 24, 2023 -
July 13, 2021 (v1)Publication
Patients with active untreated acromegaly show mild to moderate neurocognitive disorders that are associated to chronic exposure to growth hormone (GH) and insulin-like growth factor (IGF-I) hypersecretion. However, it is unknown whether these disorders improve after controlling GH/IGF-I hypersecretion. The aim of this study was to compare...
Uploaded on: March 27, 2023 -
November 26, 2020 (v1)Publication
The primary treatment for non-functioning pituitary tumors (NFPTs) is surgery, but it is often unsuccessful. Previous studies have reported that NFPTs express receptors for somatostatin (SST1-5) and dopamine (DRDs) providing a rationale for the use of dopamine agonists and somatostatin analogues. Here, we systematically assessed SST1-5 and DRDs...
Uploaded on: March 26, 2023 -
June 2, 2023 (v1)Publication
Introduction: Water and electrolyte disturbances are common after pituitary surgery and can generally be classified into transient hypotonic polyuria and transient or permanent diabetes insipidus (DI). The prevalence varies in the literature between 31-51% for transient hypotonic polyuria, 5.1-25.2% for transient DI, and 1-8.8% for permanent...
Uploaded on: June 3, 2023 -
September 16, 2022 (v1)Publication
Somatostatin receptor subtype 5 (SST5) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is poorly understood. Recently, an overlapping natural antisense transcript, SSTR5-AS1, potentially...
Uploaded on: March 24, 2023 -
September 27, 2022 (v1)Publication
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs...
Uploaded on: March 24, 2023 -
February 7, 2024 (v1)Publication
Context: Recent studies have suggested that long-term exposure to high levels of GH and IGF-I affect brain and cognitive functions. However, very few human studies have challenged this hypothesis. Objective: The aim of this study is to explore whether GH/IGF-I excess in naive patients with acromegaly alters cognitive functions, particularly...
Uploaded on: February 11, 2024 -
February 7, 2024 (v1)Publication
Background A single midnight serum cortisol (MSC) test has been reported to possess the best sensitivity and specificity for diagnosing Cushing's syndrome (CS). However, this test requires patient hospitalization, making it costly. This paper aims to compare the hospital budget impact and accuracy of using midnight salivary cortisol (MSVC), as...
Uploaded on: February 11, 2024 -
October 7, 2022 (v1)Publication
Background: Despite major medical advances, Type 1 Diabetes (T1D) patients still have greater morbimortality than the general population. Our aim was to describe our cohort of T1D patients and identify potential risk factors susceptible to prevention strategies. Methods: Cross-sectional, observational study, including T1D patients treated at...
Uploaded on: March 24, 2023 -
November 3, 2022 (v1)Publication
Objective: To describe the characteristics of the patients, as well as the treatment outcomes for the people treated in an Endocrinology and Nutrition unit with a diagnosis of SE-ED (> 7 years evolution despite evidence-based conventional treatment). Methods: A descriptive observational study was conducted. Patients with a diagnosis of SE-ED...
Uploaded on: March 24, 2023 -
October 21, 2022 (v1)Publication
The establishment of national neonatal screening systems has resulted in improved quality of life and life expectancy in patients with phenylketonuria (PKU). This has led to the development of multidisciplinary treatment units for adult patients with PKU. We present a retrospective descriptive study of a cohort of 90 adult patients (>16 years)...
Uploaded on: March 24, 2023 -
May 28, 2019 (v1)Publication
Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity. Somatostatin analogues (SSAs) represent the primary medical therapy for acromegaly and are currently used as first‐line...
Uploaded on: March 27, 2023